AMENDMENT

EXHIBIT 10.36.1

AMENDMENT

          AMENDMENT (this “Amendment”), dated as of November 30, 2010, to the Credit Agreement, dated as of July 14, 2006 (as amended, restated, supplemented or otherwise modified, this “Agreement”), among GENZYME CORPORATION, a Massachusetts corporation (the “Parent Borrower”), the SUBSIDIARY BORROWERS (the “Subsidiary Borrowers”), the several banks and other financial institutions or entities from time to time parties to this Agreement (the “Lenders”), the Syndication Agent, Co-Documentation Agents and Co-Agents named therein, and JPMORGAN CHASE BANK, N.A., as administrative agent. The parties hereto agree as follows:

WITNESSETH:

          WHEREAS, the Borrower has requested that certain provisions of the Agreement be amended as set forth herein; and

          WHEREAS, the Administrative Agent, the Issuing Bank and the Required Lenders are willing to consent to such amendments on the terms set forth herein;

          NOW THEREFORE, in consideration of the premises and mutual covenants contained herein, the undersigned hereby agree as follows:

          I. Defined Terms. Terms defined in the Agreement and used herein shall have the meanings given to them in the Agreement.

          II. Amendment to Section 1.1 (Defined Terms). Subsection 1.1 of the Agreement is hereby amended by adding the following new definition to appear in alphabetical order:

“Consolidated Total Assets”: the consolidated total asset value of the Parent Borrower and its Subsidiaries as reported in the Parent Borrower’s most recent annual report on Form 10-K filed with the SEC under the Securities Exchange Act of 1934.

          III. Amendment to Section 7.5 (Disposition of Property). Section 7.5(h) of the Agreement is hereby amended by deleting “fair market value not to exceed 15% of Consolidated Net Worth in the aggregate” therefrom and inserting in lieu thereof “net book value not to exceed 10% of Consolidated Total Assets in any fiscal year”.

          IV. Conditions to Effectiveness of Amendment. This Amendment shall become effective on the date on which the following conditions precedent have been satisfied or waived (“Effective Date”):

	(a)		The Administrative Agent shall have received a duly executed counterpart to this Amendment from the Borrower, the Administrative Agent, the Issuing Bank and the Required Lenders under the Agreement.
	(b)		The Administrative Agent shall have received payment of all of its reasonable and documented out-of-pocket costs and expenses incurred in connection with this Amendment, any other documents prepared in connection herewith and the transactions contemplated hereby, including, without limitation, the reasonable fees and disbursements of counsel to the Administrative Agent.

          V. Representations and Warranties. The Borrower hereby represents and warrants that (a) each of the representations and warranties in Section IV of the Agreement shall be, after giving

effect to this Amendment, true and correct in all material respects as if made on and as of the Effective Date (unless such representations and warranties are stated to relate to a specific earlier date, in which case such representations and warranties shall be true and correct in all material respects as of such earlier date) and (b) after giving effect to this Amendment, no Default or Event of Default shall have occurred and be continuing.

          VI. No Other Amendments; Confirmation. Except as expressly amended hereby, the provisions of the Agreement and each of the other Credit Documents are and shall remain in full force and effect.

          VII. GOVERNING LAW. THIS AMENDMENT AND THE RIGHTS AND OBLIGATIONS OF THE PARTIES HERETO SHALL BE GOVERNED BY, AND CONSTRUED AND INTERPRETED IN ACCORDANCE WITH, THE LAW OF THE STATE OF NEW YORK.

          VIII. Counterparts. This Amendment may be executed by one or more of the parties hereto on any number of separate counterparts, and all of said counterparts taken together shall be deemed to constitute one and the same instrument. This Amendment may be delivered by facsimile transmission of the relevant signature pages hereof.

[remainder of page intentionally left blank]

2

          IN WITNESS WHEREOF, the undersigned have caused this Amendment to be executed and delivered by their proper and duly authorized officers as of the day and year first above written.

	GENZYME CORPORATION
	By:	/s/ Xxxxxxx X. Xxxxx
		Name:	Xxxxxxx X. Xxxxx
		Title:	Executive Vice President Finance, Chief Financial Officer
	GENZYME GLOBAL S.A.R.L.
	By:	/s/ Xxxxxxxxxxx Xxxxxx
		Name:	Xxxxxxxxxxx Xxxxxx
		Title:	Class B Manager
	By:	/s/ Xxxxxxxx Xxxxxxx
		Name:	Xxxxxxxx Xxxxxxx
		Title:	Class A Manager
	By:	/s/ Xxxxxxx X. Xxxxx
		Name:	Xxxxxxx X. Xxxxx
		Title:	Class A Manager

	JPMORGAN CHASE BANK, N.A., as Administrative Agent and as a Lender
	By:	/s/ Xxxxx X. Xxxxxx
		Name:	Xxxxx X. Xxxxxx
		Title:	Vice President
	BANK OF AMERICA, N.A., as Syndication Agent and as a Lender
	By:	/s/ Xxxxx X. Xxxxxx
		Name:	Xxxxx X. Xxxxxx
		Title:	Vice President

	The Bank of New York Mellon
	By:	/s/ Xxxxxxxx X. Xxxx
		Name:	Xxxxxxxx X. Xxxx
		Title:	First Vice President

	The Governor & Company of the Bank of Ireland
	By:	/s/ Xxxx Xxxxxxx
		Name:	Xxxx Xxxxxxx
		Title:	Authorised Signatory
	By:	/s/ Xxxx Xxxxxx
		Name:	Xxxx Xxxxxx
		Title:	Authorized Signatory

	Intesa Sanpaolo S.p.A.-New York Branch
	By:	/s/ Xxxx Xxxxxx
		Name:	Xxxx Xxxxxx
		Title:	VP
	By:	/s/ Xxxxxxxxx XxXxxxx
		Name:	Xxxxxxxxx XxXxxxx
		Title:	FVP, Credit Manager

	KBC Bank N.V.
	By:	/s/ Xxx Xxx
		Name:	Xxx Xxx
		Title:	Director
	By:	/s/ X. Xxxxx Xxxxxxx
		Name:	X. Xxxxx Xxxxxxx
		Title:	Managing Director

	RBS Citizens, NA
	By:	/s/ Xxxxx Xxxx
		Name:	Xxxxx Xxxx
		Title:	Senior Vice President

	The Royal Bank of Scotland N.V. (formerly known as ABN AMRO Bank N.V.)
	By:	/s/ Xxxxxxx Xxxxxxxx
		Name:	Xxxxxxxx Xxxxxxxx
		Title:	Director

	Sovereign Bank
	By:	/s/ Xxxxxx X. Xxxxxxxx
		Name:	Xxxxxx X. Xxxxxxxx
		Title:	AVP

	XXXXX FARGO BANK, N.A.
	By:	/s/ Xxxxx Santa Xxxx
		Name:	Xxxxx Santa Xxxx
		Title:	Director